chitosan has been researched along with Lymphoma, B-Cell in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Argenziano, M; Bittolo, T; Bomben, R; Bozzer, S; Busato, D; Capolla, S; Cavalli, R; D'Agaro, T; Dal Bo, M; De Leo, L; Gattei, V; Macor, P; Not, T; Toffoli, G | 1 |
Albanese, S; Auletta, L; Fiorenza, D; Gramanzini, M; Greco, A; Grimaldi, AM; Iaccino, E; Netti, PA; Orlandella, FM; Palmieri, C; Quinto, I; Salvatore, G; Salvatore, M; Sandomenico, A; Sarnataro, D; Scala, G; Torino, E; Vecchione, D | 1 |
Lobato, ZI; Mansur, AA; Mansur, HS; Soriano-Araújo, A | 1 |
3 other study(ies) available for chitosan and Lymphoma, B-Cell
Article | Year |
---|---|
Targeted chitosan nanobubbles as a strategy to down-regulate microRNA-17 into B-cell lymphoma models.
Topics: Animals; Antagomirs; B-Lymphocytes; Chitosan; Humans; Lymphoma, B-Cell; Mice; MicroRNAs; Tumor Microenvironment | 2023 |
Multimodal imaging for a theranostic approach in a murine model of B-cell lymphoma with engineered nanoparticles.
Topics: Animals; Chitosan; Humans; Hyaluronic Acid; Lymphoma, B-Cell; Mice, Inbred BALB C; Mice, Nude; Multimodal Imaging; Nanoparticles; Peptide Fragments; Theranostic Nanomedicine; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |
Fluorescent nanohybrids based on quantum dot-chitosan-antibody as potential cancer biomarkers.
Topics: Antibodies, Neoplasm; Antigens, CD20; B-Lymphocytes; Biomarkers, Tumor; Cell Line, Tumor; Chitosan; Humans; Lymphoma, B-Cell; Optical Imaging; Quantum Dots | 2014 |